Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:ICCM NASDAQ:ITOC NASDAQ:OSRH NYSE:RVP On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeICCMIceCure Medical$0.24+1.7%$0.41$0.22▼$1.40$19.25M0.47574,070 shs403,335 shsITOCItonic$0.31+0.3%$0.33$0.25▼$32.00$5.29M3.232.52 million shs28,960 shsOSRHOSR$0.60-2.7%$0.54$0.38▼$1.79$21.65M0.8617.83 million shs1.12 million shsRVPRetractable Technologies$0.69-1.4%$0.68$0.60▼$1.14$20.66M1.2557,224 shs53,238 shsDon't wait for the SpaceX IPOThe space race is growing fast, and you don’t have to wait for SpaceX to go public to invest. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceICCMIceCure Medical+1.69%-3.60%-32.06%-57.72%-75.90%ITOCItonic+0.29%-8.53%+11.03%-24.70%+31,099,900.00%OSRHOSR-2.69%-13.18%+14.94%+20.97%-48.72%RVPRetractable Technologies+0.73%-1.57%+0.44%+1.47%-9.33%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeICCMIceCure Medical$0.24+1.7%$0.41$0.22▼$1.40$19.25M0.47574,070 shs403,335 shsITOCItonic$0.31+0.3%$0.33$0.25▼$32.00$5.29M3.232.52 million shs28,960 shsOSRHOSR$0.60-2.7%$0.54$0.38▼$1.79$21.65M0.8617.83 million shs1.12 million shsRVPRetractable Technologies$0.69-1.4%$0.68$0.60▼$1.14$20.66M1.2557,224 shs53,238 shsDon't wait for the SpaceX IPOThe space race is growing fast, and you don’t have to wait for SpaceX to go public to invest. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceICCMIceCure Medical+1.69%-3.60%-32.06%-57.72%-75.90%ITOCItonic+0.29%-8.53%+11.03%-24.70%+31,099,900.00%OSRHOSR-2.69%-13.18%+14.94%+20.97%-48.72%RVPRetractable Technologies+0.73%-1.57%+0.44%+1.47%-9.33%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceICCMIceCure Medical 2.40Hold$2.09767.22% UpsideITOCItonic 1.00SellN/AN/AOSRHOSR 1.00SellN/AN/ARVPRetractable Technologies 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest ITOC, OSRH, RVP, and ICCM Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/14/2026ICCMIceCure Medical Maxim GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$3.00 ➝ $1.005/8/2026ITOCItonic Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)5/4/2026ICCMIceCure Medical Alliance Global PartnersSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageBuy4/21/2026ICCMIceCure Medical Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)3/27/2026OSRHOSR Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)(Data available from 5/15/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookICCMIceCure Medical$3.38M5.79N/AN/A$0.12 per share2.01ITOCItonic$520K10.20N/AN/A$0.48 per share0.65OSRHOSR$2.91M7.24N/AN/A$4.95 per share0.12RVPRetractable Technologies$38.27M0.54$0.01 per share48.25$3.31 per share0.21Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateICCMIceCure Medical-$15.06M-$0.24N/AN/AN/A-441.60%-222.27%-119.40%N/AITOCItonic-$5.10MN/AN/AN/AN/AN/AN/AN/AN/AOSRHOSR-$27.06M-$1.28N/AN/AN/A-363.26%-7.16%-5.37%N/ARVPRetractable Technologies-$7.01M-$0.42N/AN/AN/A-41.11%-17.15%-9.33%N/ALatest ITOC, OSRH, RVP, and ICCM EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/13/2026Q1 2026OSRHOSRN/A-$0.09N/A-$0.09N/A$0.48 million5/12/2026Q1 2026ICCMIceCure Medical-$0.03-$0.06-$0.03$0.06$1.34 million$0.91 million3/30/2026Q4 2025ITOCItonicN/A-$0.0910N/A-$0.0910N/A$0.23 million3/17/2026Q4 2025ICCMIceCure Medical-$0.04-$0.06-$0.02-$0.0620$1.30 million$1.28 million2/15/2026Q4 2025ICCMIceCure MedicalN/A$0.06N/A$0.06N/A$1.28 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthICCMIceCure MedicalN/AN/AN/AN/AN/AITOCItonicN/AN/AN/AN/AN/AOSRHOSRN/AN/AN/AN/AN/ARVPRetractable TechnologiesN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioICCMIceCure MedicalN/A2.612.07ITOCItonicN/A8.838.72OSRHOSRN/A0.160.15RVPRetractable Technologies0.018.575.92Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipICCMIceCure Medical0.62%ITOCItonicN/AOSRHOSR55.30%RVPRetractable Technologies7.58%Insider OwnershipCompanyInsider OwnershipICCMIceCure Medical2.44%ITOCItonicN/AOSRHOSR60.60%RVPRetractable Technologies59.50%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableICCMIceCure Medical6081.24 million79.20 millionNot OptionableITOCItonicN/A17.05 millionN/AN/AOSRHOSRN/A35.10 million13.83 millionN/ARVPRetractable Technologies24029.94 million13.47 millionOptionableITOC, OSRH, RVP, and ICCM HeadlinesRecent News About These CompaniesRetractable Technologies Shareholders Reelect Class 2 DirectorsMay 13 at 3:10 PM | tipranks.comCritical Survey: Retractable Technologies (NYSE:RVP) & Interpace Biosciences (OTCMKTS:IDXG)May 12 at 5:07 AM | americanbankingnews.comRetractable Technologies (NYSE:RVP) Stock Price Up 2.8% - Still a Buy?May 5, 2026 | americanbankingnews.comRetractable Technologies, Inc. Announces Workforce ReductionApril 9, 2026 | businesswire.comRetractable Technologies Analyst Ratings and Price Targets | AMEX:RVP | BenzingaApril 9, 2026 | benzinga.comRVP Stock Plunges Post Q4 Earnings Despite Revenue GrowthApril 1, 2026 | zacks.comRetractable Technologies Declares Preferred Dividend Amid Tariff PressuresMarch 27, 2026 | tipranks.comRetractable Technologies: Q4 Earnings SnapshotMarch 27, 2026 | houstonchronicle.comHRetractable Technologies, Inc. Reports Results for 2025March 27, 2026 | businesswire.comRetractable Technologies, Inc. Declares Dividends to Series II and III Class B Preferred Stock ShareholdersMarch 27, 2026 | businesswire.comRVP Stock Rises Post Q3 Earnings Despite Tariff and Cost PressuresNovember 20, 2025 | zacks.comRetractable Technologies, Inc. Results for the Periods Ended September 30, 2025November 14, 2025 | businesswire.comRetractable Technologies, Inc. Receives Innovative Technology Designation from Vizient for EasyPoint Blood Collection Tube Holder with NeedleNovember 14, 2025 | businesswire.comRetractable Technologies (NYSE:RVP) CEO Thomas Shaw Purchases 15,000 SharesNovember 1, 2025 | insidertrades.comInsider Buying: Retractable Technologies (NYSE:RVP) CEO Acquires 35,000 Shares of StockOctober 30, 2025 | insidertrades.comInsider Buying: Retractable Technologies (NYSE:RVP) CEO Buys 34,506 Shares of StockOctober 29, 2025 | insidertrades.comRetractable Technologies (NYSE:RVP) CEO Acquires $13,209.72 in StockOctober 16, 2025 | insidertrades.comRetractable Technologies (NYSE:RVP) CEO Thomas Shaw Buys 30,000 SharesOctober 10, 2025 | insidertrades.comRetractable Technologies, Inc. Declares Dividends to Series II and III Class B Preferred Stock ShareholdersSeptember 30, 2025 | businesswire.comThomas Shaw Purchases 17,500 Shares of Retractable Technologies (NYSE:RVP) StockSeptember 26, 2025 | insidertrades.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeITOC, OSRH, RVP, and ICCM Company DescriptionsIceCure Medical NASDAQ:ICCM$0.24 +0.00 (+1.69%) Closing price 05/14/2026 04:00 PM EasternExtended Trading$0.24 0.00 (-1.66%) As of 05:45 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.IceCure Medical Ltd, a commercial stage medical device company, engages in the research, development, and marketing of cryoablation systems, disposables, and technologies for treating tumors. The company offers ProSense system, a single probe system for the treatment of tumors, as well as associated disposables; and IceSense3 system for ablation indications to urology, oncology, dermatology, gynecology, general surgery, thoracic surgery, and proctology. It also develops XSense system, a single probe system; and MultiSense, a multi probe system for the treatment of multiple and larger tumors. The company was incorporated in 2006 and is headquartered in Caesarea, Israel.Itonic NASDAQ:ITOC$0.31 +0.00 (+0.29%) Closing price 05/14/2026 04:00 PM EasternExtended Trading$0.32 +0.00 (+1.29%) As of 06:22 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.iTonic Holdings Ltd., a healthcare solutions provider, develops and commercializes treatment software and devices used for brachytherapy. Its proprietary treatment planning system is a radioactive particle implantation, a radiotherapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. The company offers FTTPS, a treatment planning system for treating various malignant tumors, which could determine the target volume, prescription dose, and dose limitation to protect organs at risks and produce dose distribution plan for brachytherapy for cancer patients. The company was formerly known as Pheton Holdings Ltd and changed its name to iTonic Holdings Ltd. in January 2026. iTonic Holdings Ltd. was founded in 1998 and is headquartered in Beijing, China. iTonic Holdings Ltd. operates as a subsidiary of ZJW (BVI) LTD.OSR NASDAQ:OSRH$0.60 -0.02 (-2.69%) Closing price 05/14/2026 04:00 PM EasternExtended Trading$0.59 -0.01 (-1.67%) As of 06:58 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.OSR Holdings leverages its international network of partners in the US, Europe, and South Korea to market and license its pipeline of proprietary platform technologies for broad application to efficient clinical trial programs, with the ultimate goal of addressing unmet medical needs. We partner with biotherapeutics companies with innovative and proprietary drug R&D "platform technologies" versus "assets only" companies, whose commercial viability is heavily dependent on positive results for individual treatment modalities in extremely rigorous and time consuming clinical trials. We focus on value creation through investments and collaborations with US and EU biotech companies, with the strategic goal of expansion into South Korea (specifically) and Asia (generally). OSR Holdings is headquartered in Paju, South Korea.Retractable Technologies NYSE:RVP$0.69 -0.01 (-1.43%) Closing price 05/14/2026 03:58 PM EasternExtended Trading$0.69 +0.00 (+0.29%) As of 07:09 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Retractable Technologies, Inc. designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes. It distributes its products through general line and specialty distributor; international distributors; and a direct marketing network. Retractable Technologies, Inc. was incorporated in 1994 and is headquartered in Little Elm, Texas. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas YETI Rallies After Earnings Beat and Raised Outlook Cisco’s Vertical Rally May Still Be in the Early Innings Dividend Growth or High Yield: The Income Investor's Bet Nebius Upside Expands as AI Feedback Loop Intensifies Oklo Stock Could Be Ready for Another Massive Run Amazon vs. Alibaba: One Is Clearly The Better Value Play right Now Insider Trades: Okta and Abbott See Buys, Micron Insiders Sell Qualcomm Stock Doubles: New Era? Or Another False Start? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
